Menu
1 min read · estimated
APPROVED USE
What FDA approved
Rituxan biosimilar for adults with specified CD20-positive follicular or low-grade B-cell lymphoma, previously untreated CD20-positive diffuse large B-cell lymphoma with chemotherapy, or CD20-positive chronic lymphocytic leukemia with fludarabine and cyclophosphamide.
LAMPGEN ANALYSIS
Why it matters
Added another approved rituximab biosimilar for established oncology uses.
What research teams should watch
Record the exact biologic and preserve hepatitis B screening and infusion reaction procedures.
PRIMARY RECORDS